Advanced Filters
noise

Laser Treatment Clinical Trials

A listing of Laser Treatment medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 17 clinical trials
L Lajos Kemény, professor, MD, DSc, MHAS

AdvaTx Laser Treatment for Vascular Birthmarks

The primary objective of the present study is to get experiences with the use of CE-marked ADVATx laser treatment for port-wine stains. Secondary objectives: To investigate the clinical efficacy of ADVATx laser treatment for port-wine stains. To investigate the potential side effects (erythema, hyperpigmentation, oedema, pain, swelling, skin burning, blisters) …

7 - 65 years of age All Phase N/A

Prospective Study in Laser Treatment of Pilonidal Cysts

The goal of this observational study is to evaluate the recurrence rate after laser treatment of pilonidal sinus within two years of the procedure in adult patients who require this procedure to treat their pilonidal sinus. The main question it aims to answer is: • Is there a clinical recurrence …

18 years of age All Phase N/A
L L Nguyen

Hyaluronic Acid Delivery: CO2 Laser Versus Thulium Laser Treatment

Weakly crossed-linked hyaluronic acid (HA) can be delivered through multiple injections into the dermal and subnormal layer to improve skin quality. However, this treatment comes with multiple bumps for several days. Alternatively, HA can be delivered after CO2 laser or thulium laser pretreatment. As microscopic analysis after this treatment is …

18 years of age All Phase N/A
R Rebecca Zachariah, MD

Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus

With this trial the investigators look for the effect of Laser maintenance therapy in patients with vulvar lichen sclerosus compared to the maintenance standard treatment clobetasol propionate.

18 years of age Female Phase N/A
W Wenqu Tang

Clinical Observational Study on Changes in Skin Physiological Parameters Following Ablative and Non-Ablative Fractional Laser Treatment at Different Doses

This clinical observational study investigates the dose-response relationship between laser energy intensity and skin damage/repair by applying different parameter sets of fractional ablative (CO2) and non-ablative (M22) lasers to the inner forearms of approximately 20 healthy Chinese female volunteers (aged 18-60, Fitzpatrick skin types III-V) in a single-center, self-controlled design. …

18 - 60 years of age Female Phase N/A
J Jorge Naharro-Rodriguez, M.D.

Comparative of Sequential Application of Pulsed Dye Laser and Potassium-titanyl-phosphate Laser Treatment for Capillary Malformations Versus Single Application

This prospective, non-randomized study aims to evaluate the efficacy and tolerability of treating port-wine stains (capillary malformations) using pulsed dye laser (PDL), potassium titanyl phosphate (KTP) laser, or a sequential combination of both. Each participant will receive all three treatments on different areas of the lesion. The primary outcome is …

18 years of age All Phase N/A

Evaluation of Fractional Ablative Laser Treatment for Skin Conditions

Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening

18 - 85 years of age All Phase N/A

Laser Treatment for Lichen Sclerosus

Fractional ablative laser treatment for Lichen Sclerosus lesion

18 years of age Female Phase N/A
M Maria Cristina Savastano, MD, PhD

Central Serous Chorioretinopathy and Micropulse Laser Treatment

To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone

18 - 70 years of age All Phase N/A
O Oksana V Bukina, PhD

Laser Treatment of Reticular Leg Veins vs. Sclerotherapy

Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.

18 - 75 years of age Female Phase N/A

Simplify language using AI